OTCMKTS:TXSP Taxus Pharmaceuticals (TXSP) Stock Price, News & Analysis → [Urgent!] Generational Wealth Gameplan (From Crypto 101 Media) (Ad) Free TXSP Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$27.00▼$27.0050-Day Range N/A52-Week Range$3.16▼$3.16VolumeN/AAverage VolumeN/AMarket Capitalization$2.20 billionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Taxus Pharmaceuticals alerts: Email Address Ad InvestorPlaceForget Nvidia, buy this A.I. Stock NowForget Nvidia, Microsoft or Google. Our tech expert and venture capitalist Luke Lango believes this is Elon Musk’s favorite A.I. stock. Why? Because this company is supplying Elon Musk with a key piece of advanced tech for his new A.I. venture.Click here to see the details. About Taxus Pharmaceuticals Stock (OTCMKTS:TXSP)Taxus Pharmaceuticals Holdings, Inc., a specialty retailer, sells dietary supplement products in New York. It offers vitamins, minerals, herbs, supplements, calcium, fibers, proteins, sports nutrition items, and other health and wellness products. The company was formerly known as Little Neck Health Connection, Inc. and changed its name to Taxus Pharmaceuticals Holdings, Inc. in September 2014. Taxus Pharmaceuticals Holdings, Inc. was founded in 2002 and is based in Little Neck, New York.Read More Ad InvestorPlaceForget Nvidia, buy this A.I. Stock NowForget Nvidia, Microsoft or Google. Our tech expert and venture capitalist Luke Lango believes this is Elon Musk’s favorite A.I. stock. Why? Because this company is supplying Elon Musk with a key piece of advanced tech for his new A.I. venture.Click here to see the details. TXSP Stock News HeadlinesFebruary 2, 2024 | investing.comXeris Pharmaceuticals Inc (XERS)November 6, 2022 | investing.comTaxus Cardium Pharmaceuticals Group Inc (CRXM)April 17, 2024 | InvestorPlace (Ad)Forget Nvidia, buy this A.I. Stock NowForget Nvidia, Microsoft or Google. Our tech expert and venture capitalist Luke Lango believes this is Elon Musk’s favorite A.I. stock. Why? Because this company is supplying Elon Musk with a key piece of advanced tech for his new A.I. venture.September 18, 2022 | reuters.comTXSP.PK - | Stock Price & Latest News | ReutersJanuary 16, 2022 | nasdaq.comTaxus Pharmaceuticals Hldgs Inc (TXSP)See More Headlines Receive TXSP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Taxus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today4/17/2024Fiscal Year End6/30/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Drug Stores & Proprietary Stores Sub-IndustryN/A Current SymbolOTCMKTS:TXSP CUSIPN/A CIK1622676 WebN/A Phone718-631-1522FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares81,500,000Free FloatN/AMarket Cap$2.20 billion OptionableNot Optionable Beta0.95 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. Jiayue Zhang (Age 63)Pres, CEO, CFO & Board Director Key CompetitorsPrivia Health GroupNASDAQ:PRVABeam TherapeuticsNASDAQ:BEAMRocket PharmaceuticalsNASDAQ:RCKTCelldex TherapeuticsNASDAQ:CLDXKeros TherapeuticsNASDAQ:KROSView All Competitors This page (OTCMKTS:TXSP) was last updated on 4/17/2024 by MarketBeat.com Staff From Our Partners[Urgent!] Generational Wealth GameplanCrypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTop 5 AI Stocks to Buy for 2024Market Moving TrendsOptions trading has suddenly become more reliable.Eagle PublishingTop 5 Tech Stocks to Buy for 2024Daily Market AlertsThe #1 Crypto for 2024InvestorPlaceThe Greatest Bull Market in Crypto History…Weiss Ratings[BUY ALERT] Our #1 A.I. Stock for AprilBehind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Taxus Pharmaceuticals Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.